Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Phase NGS Q1 2026 Earnings EPS Surprises to the Upside Amidst Solid Operational Execution CSV Q1 2026 Earnings Modest EPS Beat Amid Muted Market Response TCI Q1 2025 Earnings Positive EPS Delivered Amid Quiet Quarter BSAC Q1 2026 Earnings EPS Surpasses Estimates Shares Rally on Strong Performance